10 /100
LOW RISK
Score updated Jul 13, 2026

BBY — Best Buy Co., Inc. Dilution Risk Tracker

Track BBY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BBY — Get alerts when the score changes →

As of July 13, 2026, Best Buy Co., Inc. (BBY) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Best Buy Co., Inc. has a market capitalization of $16.42B, 210.77M shares outstanding, 875 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
19
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BBY.
🔔 Track BBY — Get forecast alerts →

💹 Market Data

Market Cap$16.42B
Shares Outstanding210.77M
Float195.51M
Cash$1.81B
Debt$1.17B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 17.0% shares (2026Q1 vs prior)
875 institutional holders · 258.19M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 25.57M shares
#2 BlackRock, Inc. 25.41M shares
#3 BARCLAYS PLC 16.33M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest18.22M
Days to Cover4.3
% of Float9.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 24, 2026
4 INSIDER TRANSACTION Mar 24, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BBY Shareholders

Best Buy Co., Inc. (BBY) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BBY shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BBY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BBY alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BBY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BBY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BBY
📊 BBY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BBY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.